Evidence map›Paper›PMID 32056143›Full record

ArticleInfection2020

Non-influenza respiratory viruses in adult patients admitted with influenza-like illness: a 3-year prospective multicenter study.

François Bénézit, Paul Loubet, Florence Galtier, Charlotte Pronier, Nezha Lenzi, Zineb Lesieur, Stéphane Jouneau, Gisèle Lagathu, Anne-Sophie L'Honneur, Vincent Foulongne and 12 more

Registry-linked trialOpen access · bronzeAbstract readMulticenter Study
In one paragraph

Article in Infection, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02027233 (Efficiency in Population of Influenza Vaccination for Flu Prevention of the Hospitalized Adults), which is not on this map. Cited by 24 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 3 pooled it
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02027233 nacompletednot on this map

Efficiency in Population of Influenza Vaccination for Flu Prevention of the Hospitalized Adults

TypeinterventionalSponsorInstitut National de la Santé Et de la Recherche Médicale, FranceRan2014 to 2022Enrolled6,173ConditionsSevere Acute Respiratory InfectionArmsnasopharyngeal sample
3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 3 syntheses or guidelines pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Guideline
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Observational
  18. Article
  19. Observational
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 9 institutions in 2 countries.

François BénézitUniversité Rennes-I, Service Des Maladies Infectieuses et de Réanimation Médicale, Hôpital Pontchaillou, CHU Pontchaillou, 2 rue Henri Le Guilloux, 35033, Rennes Cedex, France.
Paul LoubetUniversité Paris Descartes, Sorbonne Paris Cité; Inserm, CIC Cochin Pasteur, Innovative Clinical Research Network in VACcinology (I-REIVAC), Assistance Publique Hôpitaux de Paris, Hôpital Cochin, Paris, France.
Florence GaltierInserm, F-CRIN, Innovative Clinical Research Network in Vaccinology (I-REIVAC), Paris, France.
Charlotte PronierUniversité Rennes-I, Virologie, Hôpital Pontchaillou, Rennes, France.
Nezha LenziUniversité Paris Descartes, Sorbonne Paris Cité; Inserm, CIC Cochin Pasteur, Innovative Clinical Research Network in VACcinology (I-REIVAC), Assistance Publique Hôpitaux de Paris, Hôpital Cochin, Paris, France.
Zineb LesieurUniversité Paris Descartes, Sorbonne Paris Cité; Inserm, CIC Cochin Pasteur, Innovative Clinical Research Network in VACcinology (I-REIVAC), Assistance Publique Hôpitaux de Paris, Hôpital Cochin, Paris, France.
Stéphane JouneauUniversité Rennes-I, Pneumologie, Hôpital Pontchaillou, Rennes, France.
Gisèle LagathuUniversité Rennes-I, Virologie, Hôpital Pontchaillou, Rennes, France.
Anne-Sophie L'HonneurAHU, Service de Virologie, Hôpital Cochin, Paris, France.
Vincent FoulongneService de Virologie, CHU Montpellier, Hôpital Saint Eloi, 34295, Montpellier, France.
Christine VallejoINSERM CIC 1435, CHU Dupuytren, Limoges, France.
Sophie AlainUniv. Limoges, INSERM, CHU Limoges, RESINFIT, U1092, 87000, Limoges, France.
Xavier DuvalCIC1125, Hôpital Bichat Claude Bernard, APHP, Inserm, F-CRIN, Innovative Clinical Research Network in Vaccinology (I-REIVAC), Paris, France.
Nawal HouhouLaboratoire de Virologie, Hôpital Bichat Claude Bernard, Paris, France.
Yolande CostaCIC1125, Hôpital Bichat Claude Bernard, APHP, Inserm, F-CRIN, Innovative Clinical Research Network in Vaccinology (I-REIVAC), Paris, France.
Philippe VanhemsService D'Hygiène, Epidémiologie et Prévention, Hospices Civils de Lyon, 69437, Lyon, France.
Sélilah AmourService D'Hygiène, Epidémiologie et Prévention, Hospices Civils de Lyon, 69437, Lyon, France.
Fabrice CarratSorbonne Université, INSERM, Institut Pierre Louis D'Epidémiologie et de Santé Publique IPLESP, AP-HP, Hôpital Saint Antoine, 75013, Paris, France.
Bruno LinaHospices Civils de Lyon, Laboratoire de Virologie, Institut Des Agents Infectieux (IAI), Centre National de Référence Des Virus Respiratoires France Sud, Hôpital de La Croix-Rousse, 69317, Lyon Cedex 04, France.
Odile LaunayUniversité Paris Descartes, Sorbonne Paris Cité; Inserm, CIC Cochin Pasteur, Innovative Clinical Research Network in VACcinology (I-REIVAC), Assistance Publique Hôpitaux de Paris, Hôpital Cochin, Paris, France.
Pierre TattevinUniversité Rennes-I, Service Des Maladies Infectieuses et de Réanimation Médicale, Hôpital Pontchaillou, CHU Pontchaillou, 2 rue Henri Le Guilloux, 35033, Rennes Cedex, France. pierre.tattevin@chu-rennes.fr.ORCID http://orcid.org/0000-0003-3617-5411
FLUVAC Study Group
Collaborative Group (United States) · USInserm · FRDélégation Paris 5 · FRUniversité Claude Bernard Lyon 1 · FRHôpital Pontchaillou · FRHôpital Cochin · FRHôpital de la Croix-Rousse · FRHôpital Saint Eloi · FRHospices Civils de Lyon · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo describe the burden, and characteristics, of influenza-like illness (ILI) associated with non-influenza respiratory viruses (NIRV).

methodsWe performed a prospective, multicenter, observational study of adults admitted with ILI during three influenza seasons (2012-2015). Patients were screened for picornavirus, respiratory syncytial virus (RSV), coronavirus, human metapneumovirus, adenovirus, bocavirus, parainfluenza virus, and influenza, by PCR on nasopharyngeal samples. We excluded patients coinfected with NIRV and influenza.

resultsAmong 1421 patients enrolled, influenza virus was detected in 535 (38%), and NIRV in 215 (15%), mostly picornavirus (n = 61), RSV (n = 53), coronavirus 229E (n = 48), and human metapneumovirus (n = 40). In-hospital mortality was 5% (NIRV), 4% (influenza), and 5% (no respiratory virus). As compared to influenza, NIRV were associated with age (median, 73 years vs. 68, P = 0.026), chronic respiratory diseases (53% vs. 45%, P = 0.034), cancer (14% vs. 9%, P = 0.029), and immunosuppressive drugs (21% vs. 14%, P = 0.028), and inversely associated with diabetes (18% vs. 25%, P = 0.038). On multivariable analysis, only chronic respiratory diseases (OR 1.5 [1.1-2.0], P = 0.008), and diabetes (OR 0.5 [0.4-0.8], P = 0.01) were associated with NIRV detection.

conclusionsNIRV are common in adults admitted with ILI during influenza seasons. Outcomes are similar in patients with NIRV, influenza, or no respiratory virus.

Indexed as

AgedAged, 80 and overCoinfectionHumansMiddle AgedProspective StudiesRespiratory Tract InfectionsVirusesCoronavirusHuman metapneumovirusInfluenzaInfluenza-like illnessPicornavirusRespiratory syncytial virus

Identifiers

PMID32056143
PMCPMC7095392
OpenAlexW3006142153

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.